Class information for:
Level 1: TRABECTEDIN//ET 743//YONDELIS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
12156 864 35.7 71%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1969 5138 SYNOVIAL SARCOMA//SOFT TISSUE SARCOMA//ALVEOLAR SOFT PART SARCOMA

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TRABECTEDIN Author keyword 146 71% 14% 117
2 ET 743 Author keyword 52 77% 4% 36
3 YONDELIS Author keyword 27 92% 1% 11
4 ADVANCED SOFT TISSUE SARCOMA Author keyword 26 87% 2% 13
5 PM00104 Author keyword 21 90% 1% 9
6 SOFT TISSUE SARCOMA Author keyword 18 11% 18% 153
7 SOFT TISSUE SARCOMAS Author keyword 12 20% 6% 53
8 ECTEINASCIDIN 743 Author keyword 11 54% 2% 14
9 ADULT SARCOMA MED TREATMENT UNIT Address 11 100% 1% 6
10 ZALYPSIS Author keyword 8 100% 1% 5

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 TRABECTEDIN 146 71% 14% 117 Search TRABECTEDIN Search TRABECTEDIN
2 ET 743 52 77% 4% 36 Search ET+743 Search ET+743
3 YONDELIS 27 92% 1% 11 Search YONDELIS Search YONDELIS
4 ADVANCED SOFT TISSUE SARCOMA 26 87% 2% 13 Search ADVANCED+SOFT+TISSUE+SARCOMA Search ADVANCED+SOFT+TISSUE+SARCOMA
5 PM00104 21 90% 1% 9 Search PM00104 Search PM00104
6 SOFT TISSUE SARCOMA 18 11% 18% 153 Search SOFT+TISSUE+SARCOMA Search SOFT+TISSUE+SARCOMA
7 SOFT TISSUE SARCOMAS 12 20% 6% 53 Search SOFT+TISSUE+SARCOMAS Search SOFT+TISSUE+SARCOMAS
8 ECTEINASCIDIN 743 11 54% 2% 14 Search ECTEINASCIDIN+743 Search ECTEINASCIDIN+743
9 ZALYPSIS 8 100% 1% 5 Search ZALYPSIS Search ZALYPSIS
10 HIGH DOSE IFOSFAMIDE 7 50% 1% 10 Search HIGH+DOSE+IFOSFAMIDE Search HIGH+DOSE+IFOSFAMIDE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ECTEINASCIDIN 743 ET 743 113 92% 5% 45
2 ECTEINASCIDIN 743 95 54% 14% 122
3 ET 743 73 65% 8% 70
4 IFOSFAMIDE PLUS DOXORUBICIN 59 84% 4% 32
5 UNRESECTABLE SARCOMA 42 71% 4% 34
6 MARINE COMPOUND 33 77% 3% 23
7 ANTICANCER AGENT ECTEINASCIDIN 743 33 100% 2% 13
8 HIGH DOSE IFOSFAMIDE 27 37% 7% 58
9 UNIQUE MECHANISM 23 79% 2% 15
10 PLUS DOXORUBICIN 22 62% 3% 23

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
A Review of Trabectedin (ET-743): A Unique Mechanism of Action 2010 92 35 86%
Trabectedin, a drug acting on both cancer cells and the tumour microenvironment 2014 7 40 78%
Clinical impact of trabectedin (ecteinascidin-743) in advanced/metastatic soft tissue sarcoma 2008 27 42 93%
Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cancer 2015 2 61 43%
Bivalirudin for the Treatment of ST-Segment Elevation Myocardial Infarction: A NICE Single Technology Appraisal 2013 10 18 78%
Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma 2008 28 32 88%
Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics 2015 2 104 40%
13 years of trabectedin, 5 years of Yondelis (R): what have we learnt? 2013 6 19 95%
Trastuzumab for the Treatment of HER2-Positive Metastatic Gastric Cancer A NICE Single Technology Appraisal 2013 12 21 62%
Trabectedin- A review of its use in the management of soft tissue sarcoma and ovarian cancer 2007 56 48 75%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ADULT SARCOMA MED TREATMENT UNIT 11 100% 0.7% 6
2 SARCOMA UNIT 6 20% 3.2% 28
3 ADULT SARCOMA MED ONCOL UNIT 3 32% 0.9% 8
4 INTERDISCIPLINARY SARCOMA 3 60% 0.3% 3
5 INTERDISZIPLINA ONKOL ZENTRUM 2 67% 0.2% 2
6 BONE SOFT TISSUE SARCOMAS 2 50% 0.3% 3
7 CLIN RD 2 11% 1.7% 15
8 PHARMAMAR 1 38% 0.3% 3
9 ADULT SARCOMA MED UNIT 1 100% 0.2% 2
10 COMPREHENS CANC MUSCULOSKELETAL TUMORS 1 100% 0.2% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000231106 RENIERAMYCIN//QUINOCARCIN//SAFRAMYCIN
2 0.0000187044 SOFT TISSUE SARCOMA//RETROPERITONEAL SARCOMA//RETROPERITONEAL SARCOMAS
3 0.0000119253 IFOSFAMIDE//TROFOSFAMIDE//BNP7787
4 0.0000108071 DOLASTATIN 10//DIDEMNIN B//TZT 1027
5 0.0000090679 ENDOMETRIAL STROMAL SARCOMA//UTERINE SARCOMA//ADENOSARCOMA
6 0.0000075208 DESMOPLASTIC SMALL ROUND CELL TUMOR//DSRCT//EWS WT1
7 0.0000069189 ALVEOLAR SOFT PART SARCOMA//ALVEOLAR SOFT PART SARCOMA ASPS//ALVEOLAR SOFT PART
8 0.0000068487 ANGIOSARCOMA//CUTANEOUS ANGIOSARCOMA//ATYPICAL VASCULAR LESION
9 0.0000063616 SYNOVIAL SARCOMA//SYT SSX//SYT
10 0.0000061534 LIPOSARCOMA//DEDIFFERENTIATED LIPOSARCOMA//WELL DIFFERENTIATED LIPOSARCOMA